Altamira Therapeutics Ltd.
CYTOF
$0.0999
-$0.01-9.10%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.23% | 20.63% | 4,316.87% | 4,200.00% | -85.81% |
| Total Receivables | -86.23% | -85.95% | -89.22% | -89.47% | 34.28% |
| Inventory | -- | -- | -- | -- | 97.20% |
| Prepaid Expenses | -82.03% | -81.67% | 58.43% | 54.87% | -48.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.11% | -3.21% | -45.72% | -46.95% | -- |
| Total Current Assets | -72.89% | -72.35% | -24.07% | -25.79% | -4.26% |
|
|
|||||
| Total Current Assets | -72.89% | -72.35% | -24.07% | -25.79% | -4.26% |
| Net Property, Plant & Equipment | -3.62% | -1.72% | -80.27% | -80.72% | -18.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.34% | 8.45% | 9.81% | 7.32% | -73.79% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 16.39% | 18.70% | 34.05% | 31.01% | -64.18% |
|
|
|||||
| Total Accounts Payable | -76.01% | -75.53% | -90.49% | -90.70% | -33.77% |
| Total Accrued Expenses | -55.21% | -54.32% | -80.63% | -81.07% | -31.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -95.09% | -94.99% | -7.14% | -9.24% | 1,968.15% |
| Total Finance Division Other Current Liabilities | -- | -- | -79.55% | -79.96% | -- |
| Total Other Current Liabilities | -- | -- | -79.55% | -79.96% | -- |
| Total Current Liabilities | -79.53% | -79.12% | -92.42% | -92.59% | -41.50% |
|
|
|||||
| Total Current Liabilities | -79.53% | -79.12% | -92.42% | -92.59% | -41.50% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.44% | -3.58% | -- | -- | -23.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -86.42% | -86.15% | -72.70% | -73.32% | -0.24% |
| Total Liabilities | -80.48% | -80.10% | -90.72% | -90.93% | -27.01% |
|
|
|||||
| Common Stock & APIC | -99.97% | -99.97% | -88.55% | -88.81% | -90.38% |
| Retained Earnings | 105.67% | 105.79% | 90.16% | 90.39% | 88.46% |
| Treasury Stock & Other | 418.97% | 429.24% | 1,771.84% | 1,729.82% | 65,033.33% |
| Total Common Equity | 409.89% | 416.03% | 185.30% | 183.36% | -128.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 409.89% | 416.03% | 185.30% | 183.36% | -128.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 409.89% | 416.03% | 185.30% | 183.36% | -128.87% |
|
|
|||||